datetime,headline,summary,related,lang,source
2020-12-09 08:00:00-05:00,The Detroit Free Press Names PulteGroup’s Michigan Division a 2020 Top Workplace,"DETROIT--(BUSINESS WIRE)--National homebuilder PulteGroup, Inc. (NYSE: PHM) announced today its recognition as a 2020 Top Workplace by the Detroit Free Press. This is the third year its Michigan division has received this honor. “The Top Workplace recognition is a testament to the strong culture we have built and our commitment to creating an inclusive workplace where all employees can thrive,” said Kevin Christofferson, Michigan Division President for PulteGroup. “It is an honor to receive thi",PHM,en,Business Wire
2020-12-08 13:15:00-05:00,"PharmaMar rebota un 1,5 % después de cuatro sesiones a la baja",https://es.investing.com/news/stock-market-news/pharmamar-rebota-un-15--despues-de-cuatro-sesiones-a-la-baja-2064654,PHM,es,Investing.com Spain
2020-12-08 04:56:00-05:00,PharmaMar rebota más del 5 % después de cuatro sesiones a la baja,https://es.investing.com/news/stock-market-news/pharmamar-rebota-mas-del-5--despues-de-cuatro-sesiones-a-la-baja-2064487,PHM,es,Investing.com Spain
2020-12-07 12:28:00-05:00,"PharmaMar sufre un nuevo revés en bolsa y cae el 8,69 %",https://es.investing.com/news/stock-market-news/pharmamar-sufre-un-nuevo-reves-en-bolsa-y-cae-el-869--2064356,PHM,es,Investing.com Spain
2020-12-07 11:42:31-05:00,El Ibex cae y pierde los 8.300 puntos a la espera de un acuerdo del Brexit,"El Ibex 35 ha cerrado el arranque de la semana en rojo, con una caída del 0,57%, en este atípico lunes en el que las bolsas españolas no hacen puente. El selectivo ha perdido así los 8.300 puntos, que tanto le costó conquistar la pasada semana tras cerrarla con una subida del 1,6%. Dentro del índice han destacado las subidas de Siemens, de más de un 4%, y el desplome de PharmaMar, que se ha dejado casi un 9%.",PHM,es,Bolsamanía
2020-12-07 07:07:00-05:00,¿Se ha apagado Pharmamar? se hunde otro 10% y acumula casi un -50% desde máximos,Los inversores han comenzado a recoger beneficio ante la posibilidad de que de derrumbe el castillo de naipes al calor de anuncios relacionados con tratamientos frente al covid-19,PHM,es,El Confidencial
2020-12-07 06:34:13-05:00,Crash de Pharmamar: la biotecnológica pincha en bolsa con las vacunas Covid,La euforia con la compañía española por el uso del Aplidin como tratamiento contra el Covid-19 se desvanece desde que Pfizer y Biontech anunciaron su vacuna el 9 de noviembre.,PHM,es,La Información
2020-12-07 05:15:00-05:00,PharmaMar sufre un nuevo revés en bolsa y cae el 8 %,https://es.investing.com/news/stock-market-news/pharmamar-sufre-un-nuevo-reves-en-bolsa-y-cae-el-8--2064228,PHM,es,Investing.com Spain
2020-12-03 11:29:22-05:00,PharmaMar rellena el 'gap' alcista de mediados de junio: ahora o nunca,"A pesar de las importantes caídas de este jueves lo cierto es que si miramos al gráfico con perspectiva, desde la distancia, lo que tenemos es un amplio movimiento lateral.",PHM,es,Bolsamanía
2020-12-03 07:54:49-05:00,PharmaMar se hunde en bolsa por un mal resultado en su tratamiento de cáncer de pulmón,"Las acciones de PharmaMar llegaron a desplomarse hasta el 20% en la sesión de este jueves después de anunciar que no ha logrado los resultados esperados en la fase III de Atlantis, su tratamiento para cáncer de pulmón. Las caídas se acercaban a su…",PHM,es,La Vanguardia
2020-12-03 04:48:00-05:00,El Ibex recoge beneficio por debajo de los 8.200 con Pharmamar hundida más del 10%,La farmacéutica tira hacia abajo del selectivo desplomada tras los malos resultados de su fármaco contra el cáncer de pulmón en fase III,PHM,es,El Confidencial
2020-12-03 03:56:20-05:00,PharmaMar anuncia que no ha obtenido resultados positivos en el tratamiento contra un cáncer de pulmón microcítico,No summary available.,PHM,es,20minutos Spain
2020-12-03 03:23:27-05:00,PharmaMar no logra los resultados esperados en un tratamiento contra el cáncer,El uso de Zepzelca en combinación con otro fármaco no cumple objetivos de supervivencia,PHM,es,El Pais Cinco Dias
2020-12-03 03:20:12-05:00,PharmaMar se hunde en bolsa: uno de sus tratamientos para el cáncer fracasa,"La biotecnológica destaca que el uso de Zepzelca (lurbinectedina), tras los resultados, no ha cumplido el objetivo primario preestablecido de supervivencia global.",PHM,es,La Información
2020-12-03 03:11:19-05:00,PharmaMar: el estudio de fase III Atlantis con lurbinectedina no cumple objetivos,"PharmaMar, junto con su socio Jazz Pharmaceuticals, ha anunciado este jueves los resultados del estudio multicéntrico y aleatorio de fase III Atlantis. Este estudio evalúa Zepzelca (lurbinectedina) en combinación con doxorubicina, frente a topotecan o la combinación ciclofosfamida/doxorubicina/vincristina, a elección del investigador, para pacientes adultos con cáncer de pulmón microcítico cuya enfermedad progresó tras una línea previa de tratamiento con platino. En el brazo experimental del estudio, los pacientes recibieron 2,0mg/m2 de lurbinectedina, comparado con la dosis de 3,2mg/m2 de lurbinectedina que se administran en monoterapia, y que es la dosis que la FDA aprobó en EEUU.",PHM,es,Bolsamanía
2020-12-03 02:00:00-05:00,Jazz Pharmaceuticals and PharmaMar Announce Results of ATLANTIS Phase 3 Study Evaluating Zepzelca™ in Combination with Doxorubicin for Patients with Small Cell Lung Cancer Following One Prior Platinum-containing Line,"DUBLIN, Dec. 3, 2020 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ), along with its partner, PharmaMar (MSE: PHM), today announce results from the ATLANTIS Phase 3 multicenter, randomized, controlled study evaluating Zepzelca™ (lurbinectedin) in combination with doxorubicin…",PHM,en,PR Newswire
2020-12-02 13:58:50-05:00,"Roberto Moro: IBEX35, EURUSD, ACS, Pharmamar, Liberbank, Bitcoin, Mapfre, Codere...","Roberto Moro: IBEX35, EURUSD, ACS, Pharmamar, Liberbank, Bitcoin, Mapfre, Codere… Video Análisis realizado por el analista independiente",PHM,es,Megabolsa
2020-12-02 05:28:00-05:00,PharmaMar encabeza los descensos del IBEX por los avances en las vacunas,https://es.investing.com/news/stock-market-news/pharmamar-encabeza-los-descensos-del-ibex-por-los-avances-en-las-vacunas-2062910,PHM,es,Investing.com Spain
2020-11-24 03:25:43-05:00,PharmaMar lanza un test PCR que detecta y diferencia el covid-19 de otros virus,"Dichos test han obtenido sensibilidades de más del 95% y especificidades por encima del 99,7%",PHM,es,El Pais Cinco Dias
2020-11-24 03:07:44-05:00,PharmaMar lanza una prueba PCR que permite detectar y diferenciar las gripes,"""De esta forma se puede hacer un diagnóstico rápido y preciso, que permite a los médicos clasificar a los pacientes y determinar el tratamiento adecuado"", según la farmacéutica.",PHM,es,La Información
2020-11-23 12:15:00-05:00,"PharmaMar reduce un 1% su capital social, hasta los 11 millones de euros",https://es.investing.com/news/stock-market-news/pharmamar-reduce-un-1-su-capital-social-hasta-los-11-millones-de-euros-2059962,PHM,es,Investing.com Spain
2020-11-23 05:28:22-05:00,RBC rebaja la euforia sobre el valor estrella del año en el Ibex,El reciente correctivo otorgado a PharmaMar y el resurgir de las subidas en Solaria han ampliado drásticamente la ventaja de la empresa de renovables al frente del ránking de los v,PHM,es,Expansion
2020-11-20 15:21:15-05:00,Why PulteGroup's (NYSE:PHM) CEO Pay Issues,Why PulteGroup's (NYSE:PHM) CEO Pay Issues -,PHM,en,Fintech Zoom
2020-11-20 07:46:50-05:00,"PulteGroup, Inc. to Post FY2022 Earnings of $6.97 Per Share, Truist Securiti Forecasts (NYSE:PHM)","PulteGroup, Inc. (NYSE:PHM) – Investment analysts at Truist Securiti issued their FY2022 EPS estimates for shares of PulteGroup in a report released on Thursday, November 19th. Truist Securiti analyst R. Seth forecasts that the construction company will post earnings of $6.97 per share for the year. Truist Securiti also issued estimates for PulteGroup’s FY2023 earnings […]",PHM,en,Transcript Daily
2020-11-18 08:00:00-05:00,PulteGroup Appoints J. Phillip Holloman to its Board of Directors,"ATLANTA--(BUSINESS WIRE)--PulteGroup, Inc. (NYSE: PHM), one of America’s largest homebuilding companies, today announced the appointment of J. Phillip Holloman, former President and Chief Operating Officer (COO) of Cintas Corporation, as a new independent director to its board, effective immediately. “Phillip is a seasoned executive who successfully led one of the world’s most recognized brands for a decade,” said Bryce Blair, Chairman of the Board of PulteGroup. “We are confident his experienc",PHM,en,Business Wire
2020-11-12 12:15:00-05:00,"PharmaMar sube un 1,5 % en bolsa después de caer un 21 % en tres sesiones",https://es.investing.com/news/stock-market-news/pharmamar-sube-un-15--en-bolsa-despues-de-caer-un-21--en-tres-sesiones-2056516,PHM,es,Investing.com Spain
2020-11-12 05:42:00-05:00,PharmaMar sube más del 5 % en bolsa tras caer un 21 % en tres sesiones,https://es.investing.com/news/stock-market-news/pharmamar-sube-mas-del-5--en-bolsa-tras-caer-un-21--en-tres-sesiones-2056275,PHM,es,Investing.com Spain
2020-11-12 05:04:12-05:00,"Consultorio Bursátil: CIE Automotive, Repsol, Santander, IBEX35, Liberbank, Solaria, PharmaMar, Pfizer, IAG, Atresmedia, Vocento, DAX...","Consultorio Bursátil: CIE Automotive, Repsol, Santander, IBEX35, Liberbank, Solaria, PharmaMar, Pfizer, IAG, Atresmedia, Vocento, DAX, famacéuticas, medios de comunicación, cartera…","PHM,PFE",es,Megabolsa
2020-11-11 06:41:01-05:00,"Pharmamar, el confuso pinchazo de la nueva estrella del Ibex",Cae cerca del 20% en las tres últimas sesiones en pleno tira y afloja con la CNMV,PHM,es,El Pais Cinco Dias
2020-11-11 05:12:24-05:00,La CNMV pide a PharmaMar más detalles sobre los resultados de Aplidin contra la Covid-19,No summary available.,PHM,es,20minutos Spain
2020-11-10 12:15:00-05:00,PharmaMar cae un 9 % tras una nueva petición de información de la CNMV,https://es.investing.com/news/stock-market-news/pharmamar-cae-un-9--tras-una-nueva-peticion-de-informacion-de-la-cnmv-2055555,PHM,es,Investing.com Spain
2020-11-10 06:42:07-05:00,El Ibex 35 mantiene las subidas por los avances con la vacuna de Pfizer,"Por contra, el grupo farmacéutico PharmaMar se desploma en Bolsa tras responder a un nuevo requerimiento de información de la Comisión Nacional del Mercado de Valores (CNMV)","PHM,PFE",es,ABC Spain
2020-11-10 06:42:00-05:00,PharmaMar cae casi un 8 % tras nueva petición de información de la CNMV,https://es.investing.com/news/stock-market-news/pharmamar-cae-casi-un-8--tras-nueva-peticion-de-informacion-de-la-cnmv-2055380,PHM,es,Investing.com Spain
2020-11-10 03:18:48-05:00,PharmaMar no asegura la eficacia del Aplidin para el covid-19 y deja en el aire nuevos ensayos,La empresa no tiene planes a corto plazo para iniciar ensayos en fase III,PHM,es,El Pais Cinco Dias
2020-11-10 03:14:32-05:00,La CNMV pide a PharmaMar más datos sobre el uso de Aplidin contra el Covid,"La compañía ha reiterado que ""los datos preliminares son muy esperanzadores"" y que ""iniciará conversaciones con las agencias reguladoras para definir el próximo estudio de fase III"".",PHM,es,La Información
2020-11-09 14:49:33-05:00,El Ibex registra su mayor subida en diez años tras los avances de la vacuna de Pfizer,"El Ibex 35 ha finalizado la sesión de este lunes con un alza del 8,68%, lo que ha llevado al selectivo a situarse en los 7.467 puntos enteros, en una jornada marcada por el anuncio de Pfizer sobre los avances de su vacuna contra el coronavirus . En concreto, Pfizer y Biontech han anunciado este lunes al mediodía que su vacuna contra el Covid-19 es eficaz en más del 90% , tras el “éxito” del primer análisis intermedio de su ensayo de fase 3, lo que ha disparado las bolsas, entre ellas el Ibex 35, con el sector de viajes y el turismo liderando las subidas. Así, su candidata a vacuna basada en ARNm, BNT162b2 contra el SARS-COV-2 ha demostrado su eficacia contra el coronavirus en participantes sin evidencia previa de infección, según el primera análisis de eficacia provisional realizado el 8 de noviembre. Las pruebas han sido realizadas a un total de 43.538 participantes y el análisis ha evaluado 94 casos confirmados de Covid-19 en participantes del ensayo. No obstante, los inversores siguen atentos al impacto de la segunda ola del Covid-19, con aumento de contagios y nuevas restricciones en distintos países de Europa, entre ellos España.","PHM,PFE",es,Gaceta de Salamanca
2020-11-09 13:48:23-05:00,El Ibex 35 todavía tiene un potencial alcista del 17%,"Los valores del Ibex han devorado este lunes parte del recorrido alcista que les dan los analistas del consenso que recoge FactSet. El índice se disparó un 8,6% en la sesión, impulsado por los alentadores resultados obtenidos por Pfizer en los ensayos de su vacuna contra el Covid-19. Solo seis valores cerraron la sesión en rojo. La peor del día fue PharmaMar, que cedió un 8,2%, aunque también arrancaron la semana con pérdidas Cellnex y Solaria (que se dejaron en ambos casos algo más de un 6%), Viscofan, Siemens Gamesa y Endesa.","PHM,PFE",es,elEconomista.es
2020-11-09 08:09:06-05:00,La vacuna de Pfizer desata la euforia en la Bolsa: se dispara IAG y cae PharmaMar,"El anuncio del laboratorio Pfizer sobre la elevada efectividad de su vacuna en pruebas contra el coronavirus ha disparado las bolsas europeas. En España, el grupo IAG, matriz de Iberia, sube más de un 40%","PHM,PFE",es,Vozpopuli
2020-11-03 02:57:55-05:00,El acuerdo para la venta del fármaco Zepzelca dispara las cuentas de Pharmamar,"Gana 131 millones hasta septiembre, frente a pérdidas en 2019, y triplica sus ingresos",PHM,es,El Pais Cinco Dias
2020-11-03 02:44:00-05:00,"PharmaMar gana 131 M, frente a pérdidas en 2019, y triplica sus ingresos","El resultado bruto de explotación (Ebitda) del grupo se situó entre enero y septiembre en 143 millones, frente al Ebitda negativo de 12 millones del mismo periodo del año pasado",PHM,es,El Confidencial
2020-11-03 02:30:00-05:00,"Última hora | PharmaMar triplica ingresos y gana 131 M, frente a las pérdidas en 2019",La enfermedad que paró al mundo ha obligado a gobiernos y empresas a tomar medidas para impedir que el daño causado por las medidas de contención se haga permanente,PHM,es,El Confidencial
2020-11-02 12:31:14-05:00,"El IBEX 35 sube un 2,07% y recupera los 6.500 puntos","La Bolsa española ha cerrado este lunes con una subida del 2,07 % y el IBEX 35, su principal índice, ha recuperado el nivel de los 6.500 puntos al terminar en 6.585,60. El IBEX 35 ha subido 133,40 puntos y reduce las pérdidas acumuladas en el año al 31,04 %. El mercado nacional ha reaccionado al alza tras los datos económicos positivos y después de las f uertes caídas de la semana pasada. Las mayores subidas han sido las de ACS, con un 7,99 %; Repsol un 6,22 %, y PharmaMar un 3,82 %, y los mayores descensos han sido los de Viscofan, con un 1,64 %, Melia Hotels, con un 1,26 % y Cellnex con un 0,36 %.",PHM,es,ABC Spain
2020-10-30 11:44:00-05:00,"El Ibex cierra la semana en mínimos de marzo (-6,4%) ante la escalada del covid","'Deja vu' de marzo. Los casos de coronavirus recrudecen el colapso sanitario , los Gobiernos empiezan a tomar medidas cada vez más duras , y el banco central vuelve a cargar la pistola de estímulos. Todo en una lluvia de resultados corporativos y datos económicos que continúan sin aclarar el incierto futuro de la pandemia. En este entorno, los inversores de la bolsa han puesto los pies en polvorosa esta semana, especialmente en aquellas geografías donde abundan los valores cíclicos, como es el Ibex 35 . El índice ha sufrido en los últimos días un retroceso del 6,4% en la semana que lo ha dejado en niveles de marzo, cerrando a poco más de 300 puntos de alcanzar los mínimos del año. En apenas días, Europa ha endurecido contundentemente su gestión de la crisis. Especialmente Francia , donde su presidente Emmanuel Macron ha vaticinado que la segunda ola será ""más mortífera que la primera"" al imponer un confinamiento que durará hasta el 1 de diciembre. También Alemania ha asumido una postura más restrictiva con el coronavirus al cerrar el ocio, cultura y gastronomía .",PHM,es,El Confidencial
2020-10-28 12:15:00-05:00,PharmaMar sube a contracorriente tras fallo favorable de la justicia europea,https://es.investing.com/news/stock-market-news/pharmamar-sube-a-contracorriente-tras-fallo-favorable-de-la-justicia-europea-2051152,PHM,es,Investing.com Spain
2020-10-28 07:15:00-05:00,PharmaMar sube un 8 % en bolsa tras un fallo favorable de la justicia europea,https://es.investing.com/news/stock-market-news/pharmamar-sube-un-8--en-bolsa-tras-un-fallo-favorable-de-la-justicia-europea-2050965,PHM,es,Investing.com Spain
2020-10-28 06:36:28-05:00,El Tribunal General de la UE da la razón a PharmaMar en la resolución sobre Aplidin,Las acciones de la compañía gallega se disparan un 10% en Bolsa,PHM,es,El Pais Cinco Dias
2020-10-26 00:12:59-05:00,Los seis valores del Ibex con margen para prolongar su rally,PharmaMar conserva un potencial del 13% tras subir un 156%,PHM,es,El Pais Cinco Dias
2020-10-25 13:57:14-05:00,The FDA just approved the first coronavirus drug – but this new medicine might be even better,"Researchers tested a cancer drug called plitidepsin as a coronavirus therapy and discovered it can block the virus's ability to replicate. The use of plitidepsin reduced viral loads after just seven days and improved blood test markers for inflammation. Nearly 40% of a limited group of patients who received various doses of plitidepsin were discharged after just eight days in the hospital. Doctors looking to devise therapies that can cure patients infected with the novel coronavirus have tried all sorts of existing drugs to prevent the virus from spreading inside the body. Repurposing other drugs is a practice that yielded a few immediate results. For the time being, remdesivir and dexamethasone are the only drugs that have been shown to hasten COVID-19 recovery, with remdesivir being the first coronavirus COVID-19 drug to receive FDA approval . Blood thinners are also common coronavirus therapies to prevent blood clotting that can impact multiple organs. Other drugs weren’t as successful, including the controversial hydroxychloroquine and other therapies that looked promising in the early months of the pandemic.",PHM,en,BGR
2020-10-23 12:21:00-05:00,PharmaMar distribuiría su fármaco para Covid-19 en septiembre 2021,"Se trata de un fármaco de origen marino, concretamente en las ascidias, in microorganismo muy común en mares cálidos.",PHM,es,Forbes Mexico
2020-10-23 08:25:00-05:00,PulteGroup Does Earnings Surprise History Hold Any Clue for Stock market Insights & financial analysis,"PulteGroup announce their quarterly, annual earnings. See the latest EPS estimates. Listen to the conference call and remind yourself by…",PHM,en,Stock Market Daily
2020-10-23 06:34:45-05:00,PulteGroup (NYSE:PHM) Upgraded at 140166,"PulteGroup (NYSE:PHM) was upgraded by analysts at 140166 from a “neutral” rating to a “positive” rating in a research report issued on Friday, Briefing.com reports. The brokerage currently has a $54.00 price objective on the construction company’s stock. 140166’s target price suggests a potential upside of 26.64% from the stock’s current price. A number of […]",PHM,en, Dakota Financial News
2020-10-22 15:18:42-05:00,PulteGroup (NYSE:PHM) Stock Price Down 5.7%,"PulteGroup, Inc. (NYSE:PHM) shares were down 5.7% during mid-day trading on Thursday . The stock traded as low as $42.07 and last traded at $42.64. Approximately 6,117,393 shares changed hands during trading, an increase of 59% from the average daily volume of 3,838,459 shares. The stock had previously closed at $45.24. Several equities analysts recently […]",PHM,en,US Banking News
2020-10-22 03:38:42-05:00,"Earnings Scheduled For October 22, 2020",Companies Reporting Before The Bell • AllianceBernstein Holding (NYSE: AB ) is estimated to report quarterly earnings at $0.68 per share on revenue of $744.69 million. • American Electric Power (NASDAQ: AEP ) is estimated to report quarterly earnings at $1.45 per share on revenue of $4.41 billion. • Alaska Air Group (NYSE: ALK ) is expected to report quarterly loss at $3.01 per share on revenue of $678.20 million. • Allegion (NYSE: ALLE ) is estimated to report quarterly earnings at $1.19 per share on revenue of $666.04 million. • Ardagh Group (NYSE: ARD ) is estimated to report quarterly earnings at $0.40 per share on revenue of $1.73 billion. • Atlantic Union Bankshares (NASDAQ: AUB ) is likely to report quarterly earnings at $0.47 per share on revenue of $168.27 million. • Banc of California (NYSE: BANC ) is likely to report quarterly earnings at $0.33 per share on revenue of $59.06 million. • Check Point Software (NASDAQ: CHKP ) is expected to report quarterly earnings at $1.53 per share on revenue of $504.06 million. • Carpenter Tech (NYSE: CRS ) is likely to report quarterly loss at $0.58 per share on revenue of $371.00 million. • Dow (NYSE: DOW ) is projected to report quarterly earnings at $0.33 per share on revenue of $9.52 billion. • East West Bancorp (NASDAQ: EWBC ) is expected to report quarterly earnings at $0.95 per share on revenue of $349.08 million. • Freeport-McMoRan (NYSE: FCX ) is projected to report quarterly earnings at $0.20 per share on revenue of $3.71 billion. • Genuine Parts (NYSE: GPC ) is estimated to report quarterly earnings at $1.38 per share on revenue of $4.37 billion. • Chart Industries (NASDAQ: GTLS ) is estimated to report quarterly earnings at $0.62 per share on revenue of $301.38 million. • W.W.,PHM,en,Benzinga
2020-10-21 10:24:45-05:00,"Brokerages Anticipate PulteGroup, Inc. (NYSE:PHM) Will Post Earnings of $1.11 Per Share","Brokerages expect PulteGroup, Inc. (NYSE:PHM) to report $1.11 earnings per share (EPS) for the current quarter, according to Zacks. Four analysts have provided estimates for PulteGroup’s earnings. The lowest EPS estimate is $1.05 and the highest is $1.18. PulteGroup posted earnings of $1.01 per share during the same quarter last year, which suggests a positive […]",PHM,en,The Olympia Report
2020-10-21 10:24:44-05:00,"PulteGroup, Inc. (NYSE:PHM) Expected to Post Quarterly Sales of $2.73 Billion","Equities research analysts predict that PulteGroup, Inc. (NYSE:PHM) will announce $2.73 billion in sales for the current quarter, Zacks Investment Research reports. Four analysts have issued estimates for PulteGroup’s earnings, with the highest sales estimate coming in at $2.77 billion and the lowest estimate coming in at $2.69 billion. PulteGroup posted sales of $2.71 billion […]",PHM,en,The Olympia Report
2020-10-21 10:24:43-05:00,"Zacks: Analysts Anticipate PulteGroup, Inc. (NYSE:PHM) to Post $1.11 EPS","Analysts predict that PulteGroup, Inc. (NYSE:PHM) will post earnings of $1.11 per share for the current quarter, Zacks Investment Research reports. Four analysts have provided estimates for PulteGroup’s earnings. The highest EPS estimate is $1.18 and the lowest is $1.05. PulteGroup posted earnings per share of $1.01 during the same quarter last year, which would […]",PHM,en,The Olympia Report
2020-10-21 10:24:41-05:00,"Zacks: Brokerages Expect PulteGroup, Inc. (NYSE:PHM) Will Announce Quarterly Sales of $2.73 Billion","Analysts expect PulteGroup, Inc. (NYSE:PHM) to announce $2.73 billion in sales for the current quarter, Zacks Investment Research reports. Four analysts have made estimates for PulteGroup’s earnings. The highest sales estimate is $2.77 billion and the lowest is $2.69 billion. PulteGroup reported sales of $2.71 billion during the same quarter last year, which indicates a […]",PHM,en,The Olympia Report
2020-10-21 00:26:41-05:00,PulteGroup (PHM) to Release Quarterly Earnings on Thursday,"PulteGroup (NYSE:PHM) will be posting its quarterly earnings results before the market opens on Thursday, October 22nd. Analysts expect PulteGroup to post earnings of $1.11 per share for the quarter. Individual interested in listening to the company’s earnings conference call can do so using this link. PulteGroup (NYSE:PHM) last announced its quarterly earnings data on […]",PHM,en,Zolmax News
2020-10-19 11:14:00-05:00,"PharmaMar lidera las caídas de la Bolsa y baja el 10,51 % tras subida previa",https://es.investing.com/news/stock-market-news/pharmamar-lidera-las-caidas-de-la-bolsa-y-baja-el-1051--tras-subida-previa-2047591,PHM,es,Investing.com Spain
2020-10-19 09:27:00-05:00,PharmaMar corrige en bolsa e impulsa a un bajista especializado en farmacéuticas,Great Point Partners está especializado en el sector gracias al asesoramiento de un equipo de directivos de empresas farmacéuticas y de profesionales médicos,PHM,es,El Confidencial
2020-10-19 06:27:00-05:00,Madrid lidera un ensayo con un fármaco anticancerígeno que logra reducir la carga viral en pacientes de Covid,"La Comunidad de Madrid lidera un ensayo clínico , impulsado por la farmacéutica PharmaMar actualmente en Fase II APLICOV, con plitidepsina, un f ármaco anticancerígeno que está ofreciendo resultados positivos en reducción de carga viral en pacientes con Covid-19 que precisan ingreso hospitalario. Siete de los trece hospitales son madrileños El consejero de Sanidad, Enrique Ruiz Escudero , ha asistido hoy a la presentación de los resultados preliminares del ensayo clínico, en el que han participado 13 hospitales españoles de los que 7 son de la Comunidad de Madrid : el Hospital Universitario de La Princesa, Hospital Universitario de Getafe, Hospital Universitario Clínico San Carlos, Hospital Universitario Ramón y Cajal, el Hospital General Universitario Gregorio Marañón, HM Montepríncipe, y Hospital Quirón Madrid. La función de este fármaco es detener la replicación viral y, por tanto, juega un papel fundamental tras el inicio de los síntomas. Así, dicho estudio se ha realizado en 27 pacientes con Covid-19, de los cuales el 85% han sido tratados con plitidepsina en hospitales de la región.",PHM,es,ABC Spain
2020-10-19 04:42:00-05:00,PharmaMar cae más del 8 % en Bolsa tras las fuertes ganancias previas,https://es.investing.com/news/stock-market-news/pharmamar-cae-mas-del-8--en-bolsa-tras-las-fuertes-ganancias-previas-2047418,PHM,es,Investing.com Spain
2020-10-19 02:26:41-05:00,PharmaMar corrige un 8% en Bolsa tras las subidas del viernes,Las acciones farmacéutica española subieron más del 3% el viernes tras anunciar resultados positivos de su ensayo Aplicov contra el Covid,PHM,es,Cinco Dias El Pais
2020-10-16 18:06:30-05:00,Por qué un medicamento contra el cáncer de pulmón puede ayudar al coronavirus,"La historia de Aplidin y su relación con el Covid-19 comienza como tantos otros medicamentos que empezaron a utilizarse en plena pandemia. Un virus que no respondía a ningún tratamiento recorría el mundo y nadie tenía un remedio eficaz para detenerlo . Lo más rápido era buscar entre los medicamentos ya conocidos. PharmaMar, como tantas otras compañías empezaron a probar sus medicamentos. La compañía gallega ha orientado su actividad a buscar antitumorales en el mar. Del fondo de los océanos han surgido tratamientos como Yondelis y también Aplidin, el último compuesto desarrollado para tratar el cáncer de pulmón. No era una decisión disparatada porque han surgido antivirales de especies marinas , que los contienen de forma natural para defenderse de infecciones. Aplidin se había testado ya contra 14 tipos diferentes de virus, entre ellos el VIH, la hepatitis o la fiebre amarilla. Así que la compañía decidió probar si también tendría utilidad contra el nuevo coronavirus. Si funcionara no solo se tendría un medicamento eficaz, sino que sería un fármaco contra el covid-19, cien por cien español .",PHM,es,ABC Spain
2020-10-16 11:28:00-05:00,PharmaMar se desinfla al cierre y sube un 3 % tras haberse disparado un 11 %,https://es.investing.com/news/stock-market-news/pharmamar-se-desinfla-al-cierre-y-sube-un-3--tras-haberse-disparado-un-11--2047045,PHM,es,Investing.com Spain
2020-10-16 07:15:40-05:00,Pharmamar se dispara en Bolsa por los avances en su fármaco contra el coronavirus,"La compañía farmacéutica española PharmaMar se dispara en Bolsa tras los resultados positivos obtenidos en un ensayo clínico sobre el uso de su fármaco Aplidin para el tratamiento de la covid-19 en adultos. Cerca de las 14:00 horas, las acciones de PharmaMar ganaban un 5,53%, el mayor avance de la Bolsa española en ese momento, y se situaban en 137,6 euros. En lo que va de año, la farmacéutica acumula una subida del 194%. PharmaMar ha comunicado a la Comisión Nacional del Mercado de Valores (CNMV) que su ensayo clínico con Aplidin para el tratamiento de la covid-19 en adultos que requieren el ingreso hospitalario ha alcanzado sus objetivos de «seguridad» y «eficacia», ya que se ha comprobado una «notable» reducción de la carga viral en los enfermos. En el ensayo se han analizado tres grupos de pacientes a los que se han administrado dosis diferentes del fármaco. La carga viral de los enfermos se ha comprobado al iniciarse el tratamiento y, posteriormente, una vez transcurridos cuatro, siete, quince y treinta días.",PHM,es,ABC Spain
2020-10-16 06:51:40-05:00,"Logran ""resultados positivos"" en los ensayos de Aplidin contra la covid","Pharmamar señala que se produce ""una notable reducción de la carga viral"" en los pacientes entre los días 4 y 7 posteriores al inicio del tratamiento con este fármaco antitumoral.",PHM,es,Heraldo
2020-10-16 06:38:17-05:00,PharmaMar sube el 10% en bolsa tras demostrar la eficacia antiviral de un medicamento,"La biotecnológica española PharmaMar ha anunciado este viernes que sus ensayos clínicos con Aplidin (plitidepsina) para el tratamiento de pacientes adultos con covid-19 que requieren ingreso hospitalario han logrado ""resultados positivos"", tanto en seguridad como en eficacia. Según ha detallado la compañía en un comunicado, los resultados más recientes de sus ensayos han demostrado ""una notable reducción de la carga viral"" en los pacientes entre los días 4 y 7 posteriores al inicio del tratamiento con Aplidin, un fármaco antitumoral. Seguir leyendo… .",PHM,es,El Periodico
2020-10-16 05:57:00-05:00,PharmaMar se dispara un 11 % por los avances en su fármaco contra la covid-19,https://es.investing.com/news/stock-market-news/pharmamar-se-dispara-un-11--por-los-avances-en-su-farmaco-contra-la-covid19-2046917,PHM,es,Investing.com Spain
2020-10-16 02:01:20-05:00,PharmaMar anuncia resultados positivos de su ensayo Aplicov contra el covid-19,"El 80,7% de los pacientes han sido dados de alta médica antes del día 15 de hospitalización",PHM,es,Cinco Dias El Pais
2020-10-15 03:57:00-05:00,Grifols y PharmaMar encabezan las subidas del Ibex en una sesión bajista,https://es.investing.com/news/stock-market-news/grifols-y-pharmamar-encabezan-las-subidas-del-ibex-en-una-sesion-bajista-2046429,PHM,es,Investing.com Spain
2020-10-15 02:08:33-05:00,Pharmamar firma un acuerdo con Jazz Pharmaceuticals para comercializar lurbinectedina en Canadá,"La empresa española podrá recibir hasta 4,2 millones de euros entre el pago inicial y los pagos por hitos regulatorios en el país",PHM,es,Cinco Dias El Pais
2020-10-14 15:05:00-05:00,New Data for Zepzelca™ (lurbinectedin) to be Presented at IASLC 2020 North America Conference on Lung Cancer,"DUBLIN, Oct. 14, 2020 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) and its partner PharmaMar (MSE: PHM) today announced they will present new data for Zepzelca™ (lurbinectedin) in small cell lung cancer (SCLC) at the International Association for the Study of Lung Cancer…",PHM,en,PR Newswire
2020-10-12 02:57:00-05:00,El Ibex se viste de rojo en una jornada semifestiva pero defiende los 6.900,Pharmamar y Viscofan lideraban las ganancias aunque era IAG la que se convertía en protagonista de la sesión tras anunciar una importante remodelación de su cúpula,PHM,es,El Confidencial
2020-10-10 18:13:33-05:00,Cielo e infierno para los Fernández de Sousa,"José María Fernández de Sousa, presidente de PharmaMar, lleva años enterándose «por la prensa» de las tribulaciones empresariales de su hermano Manuel, expresidente de Pescanova y al que la Audiencia Nacional ha condenado esta semana por falsear las cuentas de la multinacional, que acabó quebrada por su gestión y en manos de la banca acreedora. Los mismos años que llevan sin hablarse. Nada. El vacío. Una saga empresarial, la misma sangre, dos caminos separados e irreconciliables. Una historia de éxito y otra de indeleble fracaso con probable epílogo en prisión. Y un apellido, Fernández, que antaño era sinónimo de poder y opulencia en Galicia, ahora demediado y con el prestigio en horas bajas. Nunca fueron uña y carne, pero había… Ver Más",PHM,es,ABC Spain
2020-09-30 07:30:00-05:00,"PulteGroup Reimagining Homes for Healthy, Work from Home Living","ATLANTA--(BUSINESS WIRE)--National homebuilder PulteGroup, Inc. (NYSE: PHM) announced a new series of Pulte Homes features designed to meet the needs of today’s homebuyers navigating the “new normal.” Based on the results of in-depth consumer research, these innovative offerings are focused on healthy living at home, added storage opportunities and creating an environment for increased home-based activities, including work, exercise, learn and play. “The pandemic has clearly changed what people",PHM,en,Business Wire
2020-09-24 07:00:00-05:00,"PulteGroup’s Third Quarter 2020 Earnings Release and Webcast Conference Call Scheduled for October 22, 2020","ATLANTA--(BUSINESS WIRE)--PulteGroup, Inc. (NYSE: PHM) today announced that it will release its third quarter 2020 financial results before the market opens on Thursday, October 22, 2020. The Company will hold a conference call to discuss its third quarter results that same day at 8:30 a.m. (ET). A live audio webcast of the call will be available on PulteGroup’s website. To listen to the webcast, log on five minutes prior to the call at www.pultegroup.com and select the Events & Presentatio",PHM,en,Business Wire
2020-09-21 16:44:06-05:00,"PharmaMar y Viscofan, entre las que mejor resisten 2020","La segunda ola de la pandemia ya comienza a recorrer de nuevo los países europeos y los posible estragos ya comienzan a notarse en los parqués. Con todo, hay dos firmas en el Ibex 35 cuyos cimientos se han reforzado durante estos meses y han aguantado las réplicas en los mercados ante las incertidumbres que trae el coronavirus. Estas son Viscofan y PharmaMar, recién llegada al índice español de referencia en sustitución de Ence.",PHM,es,elEconomista.es
2020-09-21 11:15:00-05:00,PharmaMar baja el 5 % en su estreno en el IBEX 35,https://es.investing.com/news/stock-market-news/pharmamar-baja-el-5--en-su-estreno-en-el-ibex-35-2038913,PHM,es,Investing.com Spain
2020-09-21 07:00:00-05:00,CIT Provides $20 Million Credit Facility for Protech Home Medical,"NEW YORK, Sept. 21, 2020 /PRNewswire/ -- CIT Group Inc. (NYSE: CIT) today announced that its Healthcare Finance group, part of the company's Commercial Finance division, provided a $20 million senior secured credit facility for Protech Home Medical Corp. (TSXV: PTQ) (OTCQX: PTQQF), a…",PHM,en,PR Newswire
2020-09-21 05:46:50-05:00,El Ibex pierde más de un 3% y toca niveles de mayo,"La Bolsa perdía un 3,56% en la media sesión de este lunes, lo que llevaba al selectivo a situarse en los 6.683,4 enteros a las 12.01 horas. Unos niveles que no tocaba desde el pasado mes de mayo. La jornada está marcada por los temores a los rebrotes del Covid-19 y a nuevos confinamientos y en la que la fusión entre Caixabank y Bankia sigue siendo protagonista en el sector bancario. De esta forma, el selectivo madrileño se teñía completamente de 'rojo', después de que las agencias de calificación crediticia Moody's y S&P Global hayan decidido mantener sus respectivos ratings soberanos asignados a España, situados en 'Baa1' y 'A', respectivamente. Asimismo, los inversores tienen puesta la vista en PharmaMar, incorporado este lunes al Ibex 35, que estará integrado por 34 valores hasta el próximo 19 de octubre, tras la suspensión de MásMóvil por la opa de Lorca Telecom Bidco. La farmacéutica, que ocupa el hueco que deja Ence, valor que abandona este índice para incorporarse al 'Ibex Medium Cap', cedía un 3,9% a mediodía.",PHM,es,ABC Spain
2020-09-21 03:42:00-05:00,PharmaMar se estrena en el IBEX y en su primera hora cosecha pérdidas del 3 %,https://es.investing.com/news/stock-market-news/pharmamar-se-estrena-en-el-ibex-y-en-su-primera-hora-cosecha-perdidas-del-3--2038731,PHM,es,Investing.com Spain
2020-09-21 03:26:02-05:00,PharmaMar debuta en el Ibex con caídas del 2%,"Desde el anuncio de su entrada al índice hasta hoy, sus acciones subieron un 17%",PHM,es,Cinco Dias El Pais
2020-09-20 19:00:00-05:00,PharmaMar entra en el Ibex 35: Las 5 claves de este lunes en Europa,PharmaMar entra en el Ibex 35: Las 5 claves de este lunes en Europa,PHM,es,Investing.com Spain
2020-09-20 03:43:00-05:00,PharmaMar se estrena el lunes en el Ibex 35 en sustitución de Ence,https://es.investing.com/news/stock-market-news/pharmamar-se-estrena-el-lunes-en-el-ibex-35-en-sustitucion-de-ence-2038565,PHM,es,Investing.com Spain
2020-09-19 01:56:32-05:00,"PharmaMar, dosis de salud y volatilidad para el Ibex","La compañía, que se estrena el lunes en el selectivo, sigue sujeta a fuertes oscilaciones aunque ha entrado en beneficios y asegura preparar un fármaco para tratar el Covid-19",PHM,es,Cinco Dias El Pais
2020-09-18 04:01:00-05:00,"Ence se despide al alza del Ibex 35 y su sustituto, PharmaMar, también sube",https://es.investing.com/news/stock-market-news/ence-se-despide-al-alza-del-ibex-35-y-su-sustituto-pharmamar-tambien-sube-2038142,PHM,es,Investing.com Spain
2020-09-15 23:22:25-05:00,Los nuevos miembros del Ibex son los más pequeños en cinco años,Almirall y PharmaMar valen menos de 2.000 millones de euros,PHM,es,Cinco Dias El Pais
2020-09-15 06:35:52-05:00,PharmaMar recupera los 100 euros por acción a pocos días de su estreno en el Ibex 35,"A las acciones de PharmaMar le están sentando muy bien la perspectiva de entrar en el Ibex 35. Suben más de un 6% y recupera los 100 euros, unos niveles que había abandonado el pasado mes de julio. En concreto, cotizan alrededor de los 106 euros. La compañía entra el próximo lunes en el Ibex 35 sustituyendo a Ence.",PHM,es,elEconomista.es
2020-09-15 06:14:00-05:00,PharmaMar supera los cien euros por acción a una semana de entrar en el Ibex,https://es.investing.com/news/stock-market-news/pharmamar-supera-los-cien-euros-por-accion-a-una-semana-de-entrar-en-el-ibex-2036873,PHM,es,Investing.com Spain
2020-09-14 10:30:17-05:00,Qué acciones configurarán el Ibex 35 tras su última actualización,"Tras la salida de Ence y la llegada de PharmaMar, el CAT deberá buscar sustituta a MásMóvil si sale la OPA. Esta será la nueva configuración del Ibex 35.",PHM,es,IG
2020-09-11 11:15:00-05:00,"PharmaMar sube un 7,75 % ante su próxima entrada en el IBEX 35",https://es.investing.com/news/stock-market-news/pharmamar-sube-un-775--ante-su-proxima-entrada-en-el-ibex-35-2036073,PHM,es,Investing.com Spain
2020-09-11 07:28:00-05:00,"PharmaMar sube un 4,64 % ante su próxima entrada en el IBEX 35",https://es.investing.com/news/stock-market-news/pharmamar-sube-un-464--ante-su-proxima-entrada-en-el-ibex-35-2035999,PHM,es,Investing.com Spain
2020-09-10 11:19:19-05:00,PharmaMar sustituirá a Ence en el Ibex 35 el próximo 21 de septiembre,Ence ocupará su lugar en el índice 'Ibex Medium Cap',PHM,es,Vozpopuli
2020-09-09 23:18:59-05:00,PharmaMar y Logista se disputan el puesto que dejará MásMóvil en el Ibex,"La teleco saldrá el lunes del selectivo, que se quedará con 34 valores",PHM,es,Cinco Dias El Pais
2020-09-09 15:55:00-05:00,PulteGroup Announces Quarterly Cash Dividend of $0.12 Per Share,"ATLANTA--(BUSINESS WIRE)--PulteGroup, Inc. (NYSE: PHM) announced today that its Board of Directors has declared a quarterly cash dividend of $0.12 per common share payable October 6, 2020, to shareholders of record at the close of business on September 21, 2020. About PulteGroup PulteGroup, Inc. (NYSE: PHM), based in Atlanta, Georgia, is one of America’s largest homebuilding companies with operations in 40 markets throughout the country. Through its brand portfolio that includes Centex, Pulte H",PHM,en,Business Wire
2020-08-24 07:00:00-05:00,Sales Soar at PulteGroup’s New Affordably Priced Communities,"ATLANTA--(BUSINESS WIRE)--Homebuilder PulteGroup, Inc. (NYSE: PHM) is expanding its offering of affordably priced homes under its national Centex brand. Through its new community format, the company is extending the brand’s portfolio to include more value-oriented communities that can better meet the needs of today’s entry-level homebuyers. In a recent survey by PulteGroup, the majority of consumers say insufficient savings is the biggest financial hinderance to buying a new home. Keeping cost",PHM,en,Business Wire
2020-08-10 03:16:05-05:00,PharmaMar firma un acuerdo para la comercialización de Yondelis en Turquía,https://es.investing.com/news/stock-market-news/pharmamar-firma-un-acuerdo-para-la-comercializacion-de-yondelis-en-turquia-2027203,PHM,es,Investing.com Spain
2020-08-10 02:37:00-05:00,PharmaMar firma un nuevo acuerdo con Onko para comercializar Yondelis en Turquía,"PharmaMar ha firmado un acuerdo de licencia con Onko Ilac San ve Tic para comercializar el fármaco antitumoral de origen marino Yondelis (trabectedina) en Turquía. En concreto, según los términos del acuerdo, PharmaMar recibirá un pago inicial no revelado y tendrá derecho a ingresos adicionales, incluidos pagos por hitos regulatorios. Además, PharmaMar conservará los derechos exclusivos de producción y venderá el producto a Onko para su uso comercial y clínico. Este nuevo acuerdo se produce tras el anuncio de PharmaMar el 26 de agosto de 2019 del acuerdo firmado con Janssen Products LP (Janssen), por el que PharmaMar recuperó los derechos de comercialización del producto en más de 40 países, anteriormente licenciados a Janssen, en los que trabectedina ya ha sido aprobada. Actualmente, Janssen suministra trabectedina a pacientes en Turquía para el tratamiento del sarcoma de tejidos blandos y, a través de esta licencia, Onko también solicitará la aprobación de las autoridades reguladoras para la indicación del cáncer de ovario recurrente.",PHM,es,El Confidencial
2020-07-30 06:57:00-05:00,"PharmaMar ganó 113,8 millones en el primer semestre impulsado por oncología",https://es.investing.com/news/stock-market-news/pharmamar-gano-1138-millones-en-el-primer-semestre-impulsado-por-oncologia-2024100,PHM,es,Investing.com Spain
2020-07-27 11:40:21-05:00,PulteGroup: One Of The Great Ones To Buy On Dips (NYSE:PHM),PulteGroup is up 10% despite an ugly recession and rising unemployment. The company crushed second-quarter expectations and reported a strong rise in new orders towards the end of the quarter.,PHM,en,Seeking Alpha
2020-07-27 03:01:57-05:00,Pharma Mar S A : PharmaMar signs a new agreement with ADIUM PHARMA S.A. to commercialize Yondelis® in Latin America | MarketScreener,"PharmaMar signs a new agreement with ADIUM PHARMA S.A. to commercialize Yondelis® in Latin America PharmaMar will receive an upfront payment and is… | July 27, 2020",PHM,en,MarketScreener
2020-07-23 06:03:03-05:00,"PulteGroup profit beats as low mortgage rates, preference for suburbs boost sales","U.S. homebuilder PulteGroup Inc reported a better-than-expected quarterly profit on Thursday, as low mortgage rates and a shift towards suburbs brought on by the coronavirus pandemic encouraged more Americans to buy a house.",PHM,en,Reuters
2020-07-23 05:34:20-05:00,"PulteGroup EPS beats by $0.29, beats on revenue (NYSE:PHM)",PulteGroup (NYSE:PHM): Q2 Non-GAAP EPS of $1.15 beats by $0.29; GAAP EPS of $1.29 beats by $0.41. Revenue of $2.59B (+4.0% Y/Y) beats by $60M. New orders U,PHM,en,Seeking Alpha
2020-07-23 05:30:00-05:00,PulteGroup Reports Second Quarter 2020 Financial Results,"ATLANTA--(BUSINESS WIRE)--PulteGroup, Inc. (NYSE: PHM) announced today financial results for its second quarter ended June 30, 2020. For the quarter, the Company reported net income of $349 million, or $1.29 per share. Adjusted net income for the period was $311 million, or $1.15 per share, after excluding $61 million of pre-tax benefit from an insurance reserve adjustment and $10 million of pre-tax severance charges resulting from previously announced staffing actions taken in the period. The",PHM,en,Business Wire
2020-07-23 02:11:52-05:00,PharmaMar prueba un antitumoral contra el Covid,"La biofarmacéutica gallega fía a Aplidin, su compuesto para el mieloma múltiple, la cura del SARS-CoV-2",PHM,es,Cinco Dias El Pais
2020-07-21 10:48:00-05:00,PharmaMar corta su escalada en bolsa con un revés del 15%,"La compañía registra su mayor caída desde el pasado marzo, entre las dudas de los analistas sobre la racionalidad de las valoraciones alcanzadas",PHM,es,El Confidencial
2020-07-20 06:16:24-05:00,PharmaMar solicita la autorización temporal para la comercialización de lurbinectedina en Suiza,https://es.investing.com/news/stock-market-news/pharmamar-solicita-la-autorizacion-temporal-para-la-comercializacion-de-lurbinectedina-en-suiza-2020218,PHM,es,Investing.com Spain
2020-07-20 05:36:08-05:00,Pharma Mar S A : PharmaMar has filed lurbinectedin for Temporary Marketing Authorisation with the Swiss Agency for Therapeutic Products | MarketScreener,"PharmaMar has filed lurbinectedin for Temporary Marketing Authorisation with the Swiss Agency for Therapeutic Products The Company has filed for… | July 20, 2020",PHM,en,MarketScreener
2020-07-13 10:39:44-05:00,PharmaMar anuncia que lurbinectedina es recomendado por guías de oncología,"PharmaMar ha anunciado que Zepzelca (lurbinectedina) ha sido incluido en las Guías de Práctica Clínica en Oncología (NCCN Guidelines) como tratamiento recomendado para el cáncer de pulmón microcítico,. PharmaMar anuncia que lurbinectedina es recomendado por guías de oncología | Empresas | Agencia EFE",PHM,es,EFE News Service
2020-06-29 09:20:00-05:00,PharmaMar tiene luz verde para ensayar clínicamente la lurbinectidina en China,"PharmaMar ha anunciado este lunes, junto con su socio en China, Luye Pharma Group, que la solicitud de ensayo clínico de lurbinectedina para cáncer de pulmón microcítico ha recibido la aceptación formal del Centro de Evaluación de Medicamentos (CDE, Centre for Drug Evaluation) de la República Popular China. Con esta aceptación, se permite a Luye Pharma iniciar nuevos ensayos clínicos con lurbinectedina en la población china , ya que es un requisito de las autoridades reguladoras. En abril del pasdado año, PharmaMar y Luye Pharma firmaron un acuerdo de licencia de desarrollo y comercialización con respecto a lurbinectedina, por el que PharmaMar recibió 5 millones de dólares (4,43 millones de euros). Última hora | El IPC sube seis décimas y rompe la racha de tres meses de retrocesos Cotizalia / Agencias La enfermedad que ha parado al mundo ha obligado a los Gobiernos y compañías a tomar medidas para impedir que el daño causado por el parón se convierta en permanente Según los términos del acuerdo, Luye Pharma está comprometida a desarrollar lurbinectedina para el tratamiento del cáncer de pulmón microcítico en China , mientras que PharmaMar conserva los derechos exclusivos de producción del compuesto.",PHM,es,El Confidencial
2020-06-29 04:57:02-05:00,PharmaMar recibe un pago de 100 millones de dólares tras la aprobación de un fármaco en EEUU,El grupo farmacéutico PharmaMar anunció el lunes que ha recibido un pago de 100 millones de dólares de Jazz Pharmaceuticals tras aprobar el regulador estadounidense uno de sus anticancerígenos.,PHM,es,Reuters Latin America
2020-06-25 07:00:00-05:00,"PulteGroup’s Second Quarter 2020 Earnings Release and Webcast Conference Call Scheduled for July 23, 2020","PulteGroup, Inc. (NYSE: PHM) today announced that it will release its second quarter 2020 financial results before the market opens on Thursday, July",PHM,en,Business Wire
2020-06-25 02:01:00-05:00,Oryzon ampliará capital en 20 M (el 14%) de cara a su posible entrada en el Nasdaq,"El consejo de administración de Oryzon Genomics ha acordado aumentar el capital social en un importe efectivo de 20.000.750,00 euros mediante la emisión y puesta en circulación de 7.273.000 acciones ordinarias de 0,05 euros de valor nominal cada una, con exclusión del derecho de suscripción preferente. La empresa tiene una capitalización bursátil de 141 millones, por lo que la cantidad ampliada representa alrededor del 14% del total. La firma tiene la intención de utilizar los ingresos netos obtenidos en el aumento de capital para financiar la investigación y desarrollo de sus programas clínicos, así como para continuar con la preparación de la potencial admisión a negociación ('dual listing') de sus acciones en el Nasdaq y para otros fines corporativos generales. Siete diferencias entre PharmaMar y Oryzon al vender sus 'avances' sobre el covid-19 Carlos Hernanz José María Fernández Sousa lleva más de un mes alimentando las expectativas sobre el posible uso de su medicamento El precio de emisión será de 2,75 euros por acción, de los que 0,05 euros corresponden a valor nominal y 2,70 euros a prima de emisión, con un descuento del 10,7% sobre el precio de cierre del 23 de junio (3,08 euros), según ha informado este jueves la compañía a la Comisión Nacional del Mercado de Valores (CNMV).",PHM,es,El Confidencial
2020-06-23 05:58:27-05:00,Pharma Mar S A : PharmaMar to Present at the Upcoming Virtual European Biotech Investor Day 2020 | MarketScreener,"PharmaMar to Present at the Upcoming Virtual European Biotech Investor Day 2020 Madrid, June 23rd, 2020.- PharmaMar has announced today… | June 23, 2020",PHM,en,MarketScreener
2020-06-23 03:03:00-05:00,Seis cotizadas españolas reparten dividendos en los próximos días,"Mapfre, FCC, Corporación Financiera Alba, Cellnex, Ebro Foods y PharmaMar retribuirán a sus accionistas durante esta semana y la próxima",PHM,es,El Confidencial
2020-06-11 07:00:00-05:00,Social Media Sparks New Home Sales for PulteGroup,"ATLANTA--(BUSINESS WIRE)--No longer just a place to connect with friends, post photos and videos and share status updates, social media is now serving a new function for users looking for their dream home. One of the nation’s largest homebuilders, PulteGroup (NYSE: PHM) is leveraging live Facebook events to help bring its new communities and homes to meet consumers where they already are: online. “Social media presented an innovative and exciting opportunity to debut our new community during a",PHM,en,Business Wire
2020-06-02 06:00:00-05:00,OTC Markets Group Welcomes Protech Home Medical Corp. to OTCQX,"NEW YORK, June 2, 2020 /PRNewswire/ -- OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, today announced Protech Home Medical Corp. (TSX-V: PTQ; OTCQX: PTQQF), a provider of in-home monitoring and disease management services…",PHM,en,PR Newswire
2020-05-28 07:00:00-05:00,PulteGroup’s Built to Honor Program Partners with Operation FINALLY HOME and the Houston Texans to Award Mortgage-Free Home to Purple Heart Veteran,"HOUSTON--(BUSINESS WIRE)--U.S. Army Sergeant First Class Justin Reuber recently received the keys to his new mortgage-free and fully-furnished Centex home in the Windrow community in Hockley, Texas. The home was donated by PulteGroup’s Built to Honor® program, which provides the gift of a new home to wounded veterans and their families across the country. In a small, socially distanced ceremony, SFC Reuber, his wife Hana and their three children saw their new home for the first time. The four b",PHM,en,Business Wire
2020-05-23 10:30:38-05:00,PulteGroup (PHM) Up 39.6% Since Last Earnings Report: Can It Continue?,PulteGroup (PHM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.,PHM,en,Zacks Investment Research
2020-05-13 06:23:00-05:00,PulteGroup (PHM) Slashes Costs on Weak Net Order Growth,"PulteGroup (PHM) has been reducing costs through layoffs, furloughs and other actions as April order rates are down 50% year over year.",PHM,en,Zacks Investment Research
2020-05-11 06:30:00-05:00,"PulteGroup, Inc. Provides Update on COVID-19 Impacts and Response Actions","ATLANTA--(BUSINESS WIRE)--PulteGroup, Inc. (NYSE: PHM) today provided an update on actions the Company has taken in response to the COVID-19 pandemic. “As part of our first quarter earnings release, we reported that following a very strong start to the year, housing demand slowed materially beginning in mid-March as the country was impacted by the COVID-19 pandemic,” said Ryan Marshall, PulteGroup President and CEO. “In response to the pandemic, we quickly modified our sales, construction and a",PHM,en,Business Wire
2020-05-08 16:08:00-05:00,Battered Builder Stocks Could Be Hot Properties Again,"Lennar, PulteGroup, M/I Homes, and Toll Brothers look like buys, says a researcher who foresaw the housing crash that fueled the financial crisis. Why she has Sells on three real estate investment trusts.",PHM,en,Barron's
2020-05-06 05:30:00-05:00,PulteGroup’s Presentation as Part of the J.P. Morgan Homebuilding & Building Products Conference to Be Webcast Live,"ATLANTA--(BUSINESS WIRE)--PulteGroup, Inc. (NYSE: PHM), will present virtually at the J.P. Morgan Homebuilding & Building Products Conference on Tuesday, May 19, 2020, at 11:00 a.m. (EDT). Interested investors can access the webcast of PulteGroup’s presentation by logging onto the Company’s website at www.pultegroup.com and selecting the Events & Presentations link under the Investor Relations tab. Participants are encouraged to log on at least five minutes prior to the start of the pre",PHM,en,Business Wire
2020-04-27 11:03:57.705000-05:00,"PulteGroup Says New Home Sales Plunging, Stops Stock Guidance Until ""Conditions Stabilize""",PulteGroup says new home sales plunged as pandemic gained traction.,PHM,en,The Motley Fool
2020-04-23 13:57:27-05:00,"PulteGroup's stock slips, as buyer traffic 'decreased materially' in April after orders sank in March","Shares of PulteGroup Inc. undefined slipped 0.2% in afternoon trading Thursday, to buck the rally among its home builder peers and the broader stock market,…",PHM,en,MarketWatch
2020-04-23 06:45:05-05:00,PulteGroup (PHM) Q1 Earnings Surpass Estimates,"PulteGroup (PHM) delivered earnings and revenue surprises of 5.71% and -1.62%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?",PHM,en,Zacks Investment Research
2020-04-20 09:57:00-05:00,PulteGroup (PHM) to Report Q1 Earnings: What's in Store?,"PulteGroup's (PHM) Q1 results are likely to benefit from high demand for homes, buyouts & cost-saving actions. Lower ASPs, higher land/labor costs & shutdowns due to coronavirus may have been woes.",PHM,en,Zacks Investment Research
2020-04-16 11:32:01-05:00,PulteGroup (PHM) Earnings Expected to Grow: What to Know Ahead of Next Week's Release,PulteGroup (PHM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.,PHM,en,Zacks Investment Research
2020-04-09 09:15:00-05:00,"Zacks Market Edge Highlights: Home Depot, KB Home, Pulte Group, Wayfair and United Rentals","Zacks Market Edge Highlights: Home Depot, KB Home, Pulte Group, Wayfair and United Rentals",PHM,en,Zacks Investment Research
2020-03-12 03:40:00-05:00,Should Value Investors Consider PulteGroup (PHM) Stock Now?,Let's see if PulteGroup (PHM) stock is a good choice for value-oriented investors right now from multiple angles.,PHM,en,Zacks Investment Research
2020-02-27 11:30:37-05:00,Why Is PulteGroup (PHM) Down 8.6% Since Last Earnings Report?,PulteGroup (PHM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.,PHM,en,Zacks Investment Research
2020-02-19 12:45:06-05:00,PulteGroup (PHM) is an Incredible Growth Stock: 3 Reasons Why,"PulteGroup (PHM) is well positioned to outperform the market, as it exhibits above-average growth in financials.",PHM,en,Zacks Investment Research
2020-01-31 12:20:05-05:00,Earnings Estimates Rising for PulteGroup (PHM): Will It Gain?,"PulteGroup (PHM) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.",PHM,en,Zacks Investment Research
2020-01-28 14:14:36-05:00,PulteGroup Stock Climbs on Home Contracts and Earnings Beat,PulteGroup shares were higher after the homebuilder reported better-than-expected quarterly orders and an earnings win.,PHM,en,The Street
2020-01-28 07:45:03-05:00,PulteGroup (PHM) Tops Q4 Earnings and Revenue Estimates,"PulteGroup (PHM) delivered earnings and revenue surprises of 5.56% and 1.54%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?",PHM,en,Zacks Investment Research
2020-01-28 06:30:00-05:00,PulteGroup Reports Fourth Quarter 2019 Financial Results,"ATLANTA--(BUSINESS WIRE)--PulteGroup, Inc. (NYSE: PHM) announced today financial results for its fourth quarter ended December 31, 2019. For the quarter, the Company reported net income of $336 million, or $1.22 per share. Adjusted net income for the period was $312 million, or $1.14 per share, after excluding $31 million of pre-tax benefit from an insurance reserve adjustment. Reported net income for the fourth quarter of 2018 was $238 million, or $0.84 per share. Adjusted net income for the f",PHM,en,Business Wire
2020-01-22 03:19:00-05:00,Will Higher Expenses Mar PulteGroup (PHM) Q4 Earnings?,"Despite benefiting from acquisitions and cost-saving actions, PulteGroup's (PHM) Q4 results are likely to be hurt by higher costs and expenses.",PHM,en,Zacks Investment Research
2020-01-21 08:44:16-05:00,Four stocks traders are picking to capitalize on the US homebuilding boom,"PulteGroup, KB Home, Home Depot and Lowe's are traders' top picks for investors looking to buy into the U.S. homebuilding boom.",PHM,en,CNBC
2020-01-21 07:00:00-05:00,"A Stalwart Value Investor Sold FedEx, JPMorgan and Morgan Stanley Stock","Edgar Wachenheim III’s Greenhaven Associates made the changes in the fourth quarter, along with selling PulteGroup stock.",PHM,en,MarketWatch
2020-01-16 03:01:00-05:00,Will PulteGroup (PHM) Generate Better Earnings in 2020?,"PulteGroup (PHM) is poised to benefit from land acquisition strategy and solid housing market backdrop. However, cost woes persist.",PHM,en,Zacks Investment Research
2019-12-20 12:00:26-05:00,Billionaire's grandson Bill Pulte wants to give Bitcoin to people in Africa | CryptoSlate,"Bill Pulte, the heir to the Detroit real estate giant PulteGroup, has set his sights on sending Bitcoin to those in need living in Africa. Pulte, who gained popularity by giving out hundreds of thousands of dollars to strangers on Twitter, is big on Bitcoin and believes it could be used to fight poverty in …",PHM,en,CryptoSlate
2019-12-19 11:19:00-05:00,"PulteGroup’s Fourth Quarter 2019 Earnings Release and Webcast Conference Call Scheduled for January 28, 2020","ATLANTA--(BUSINESS WIRE)--PulteGroup, Inc. (NYSE: PHM) today announced that it will release its fourth quarter 2019 financial results before the market opens on Tuesday, January 28, 2020. The Company will hold a conference call to discuss its fourth quarter results that same day at 8:30 a.m. (ET). A live audio webcast of the call will be available on PulteGroup’s website. To listen to the webcast, log on five minutes prior to the call at www.pultegroup.com and select the Events & Presentati",PHM,en,Business Wire
2019-12-13 06:37:00-05:00,Bull of the Day: PulteGroup (PHM),Bull of the Day: PulteGroup (PHM),PHM,en,Zacks Investment Research
2019-11-21 09:30:51-05:00,Why Is PulteGroup (PHM) Down 0.5% Since Last Earnings Report?,PulteGroup (PHM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.,PHM,en,Zacks Investment Research
2019-11-15 08:30:00-05:00,PulteGroup’s Michigan Division Named a 2019 Top Workplace by The Detroit Free Press,"DETROIT--(BUSINESS WIRE)--PulteGroup, Inc. (NYSE: PHM) announced today that its Michigan division has been awarded a 2019 Top Workplaces honor by The Detroit Free Press. Award winners are selected based on nominations and an evaluation of the company’s organizational health and engagement as submitted by their employees. “It is an honor to be named a Top Workplace in Michigan. We are passionate about creating an engaging culture that inspires employees to do their best work, and it is incredibl",PHM,en,Business Wire
2019-11-14 03:24:00-05:00,PulteGroup Arm & Paymentus Unite to Simplify Mortgage Process,PulteGroup (PHM) is set to boost customer experience via its recent partnership with Paymentus.,PHM,en,Zacks Investment Research
2019-10-23 08:15:10-05:00,PulteGroup (PHM) Hits Fresh High: Is There Still Room to Run?,"PulteGroup (PHM) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.",PHM,en,Zacks Investment Research
2019-10-22 13:43:00-05:00,PulteGroup's stock surges toward 13-year high as effort to attract more first-time home buyers worked,"Shares of PulteGroup Inc. surged 3.1% toward a 13-year high in afternoon trading Tuesday, after the home builder reported third-quarter profit that fell less…",PHM,en,MarketWatch
2019-10-22 10:11:00-05:00,"PulteGroup (PHM) Q3 Earnings & Revenues Beat, Shares Up",Improvement in demand on the back of lower mortgage rates helps PulteGroup (PHM) to post better-than-expected Q3 earnings.,PHM,en,Zacks Investment Research
2019-10-20 17:08:51-05:00,"PulteGroup, Inc. (PHM): Hedge Funds Are Snapping Up","The Insider Monkey team has completed processing the quarterly 13F filings for the June quarter submitted by the hedge funds and other money managers included in our extensive database. Most hedge fund investors experienced strong gains on the back of a strong market performance, which certainly propelled",PHM,en,ACI Information Group
2019-10-17 05:33:00-05:00,PulteGroup (PHM) to Report Q3 Earnings: What's in the Cards?,"Although declining mortgage rates are likely to have aided PulteGroup's (PHM) Q3 earnings, lower deliveries and higher costs are expected to have weighed on the top and bottom lines.",PHM,en,Zacks Investment Research
2019-10-15 02:48:00-05:00,PulteGroup (PHM) Shares Up 43% YTD: Will the Rally Continue?,"PulteGroup (PHM) is focusing on land acquisition strategies, along with other economic factors to boost sales",PHM,en,Zacks Investment Research
2019-09-24 10:30:05-05:00,PulteGroup Shares Signal Building Demand,"Given strong institutional demand and healthy fundamentals, PulteGroup stock could be worth a spot in a growth-oriented portfolio.",PHM,en,Investopedia
2019-09-17 09:10:00-05:00,Is PulteGroup (PHM) Stock a Good Pick for Value Investors?,"Let's see if PulteGroup, Inc. (PHM) stock is a good choice for value-oriented investors right now, or if investors subscribing to this methodology should look elsewhere for top picks.",PHM,en,Zacks Investment Research
2019-09-17 04:10:00-05:00,Is PulteGroup (PHM) Stock a Good Pick for Value Investors?,"Let's see if PulteGroup, Inc. (PHM) stock is a good choice for value-oriented investors right now, or if investors subscribing to this methodology should look elsewhere for top picks.",PHM,en,Zacks Investment Research
2019-08-27 08:34:00-05:00,"The millionaire CEO who went viral after promising to donate $30,000 to a vet if Trump retweets him is now offering a $10,000 reward to help find a missing veteran","Detroit-based CEO and philanthropist Bill Pulte has gained media attention in recent months for using Twitter to offer money to ""people who need necessities, food, rent, a/c."" According to his Twitter bio , he has donated funds to people in various types of need. Pulte is now offering a $10,000 reward for information on a missing veteran, he tweeted Friday. The missing veteran, 37-year-old Jesse Conger, disappeared from Scottsdale, Arizona on August 14 without his wallet, phone, or service dog, according to the Phoenix Veterans Affairs Health Care System . Visit Business Insider's homepage for more stories. Bill Pulte, a Michigan-based CEO, has gained a following on Twitter for doing what he calls ""Twitter philanthropy"" — offering to invest $5,000 in a small business pitched to him online, buy a new car for someone who retweets him, or purchase groceries for strangers who ask online. Now, Pulte is offering a reward to help the family and friends of a missing veteran get information on his whereabouts. ""$10K DOLLAR REWARD,"" Pulte tweeted on August 24 alongside a missing person poster. ""I am offering $10,000 REWARD to the person who finds Missing Combat Veteran Jesse near LEES FERRY, AZ.",PHM,en,Business Insider
2019-08-22 08:30:48-05:00,PulteGroup (PHM) Up 6.4% Since Last Earnings Report: Can It Continue?,PulteGroup (PHM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.,PHM,en,Zacks Investment Research
2019-07-24 10:24:00-05:00,PulteGroup’s Earnings Hit the Stock. This Analyst Just Upgraded the Home Builder.,RBC Capital Markets says the earnings news was better than some investors believed.,PHM,en,Barron's
2019-07-23 09:56:52-05:00,PulteGroup Falls on Lower New Home Sales Guidance,Shares of home-construction company PulteGroup fall after the company reports second-quarter earnings that surpassed analysts' estimates but warns its third-quarter home sales will be softer than expected….PHM,PHM,en,The Street
2019-07-23 09:00:00-05:00,"PulteGroup's (PHM) Q2 Earnings & Revenues Beat, Margins Dip",Declining mortgage rates and higher home sale prices help PulteGroup (PHM) to post better-than-expected Q2 results.,PHM,en,Zacks Investment Research
2019-07-23 06:45:04-05:00,PulteGroup (PHM) Q2 Earnings and Revenues Beat Estimates,"PulteGroup (PHM) delivered earnings and revenue surprises of 4.88% and 0.51%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?",PHM,en,Zacks Investment Research
2019-07-16 09:31:37-05:00,PulteGroup (PHM) Expected to Beat Earnings Estimates: Can the Stock Move Higher?,PulteGroup (PHM) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.,PHM,en,Zacks Investment Research
2019-07-16 09:10:11-05:00,Why PulteGroup (PHM) Could Beat Earnings Estimates Again,PulteGroup (PHM) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.,PHM,en,Zacks Investment Research
2019-06-11 08:25:06-05:00,"PulteGroup (PHM) Soars to 52-Week High, Time to Cash Out?","PulteGroup (PHM) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.",PHM,en,Zacks Investment Research
2019-05-28 07:54:00-05:00,"The Zacks Analyst Blog Highlights: NVR, PulteGroup, Taylor Morrison and M/I","The Zacks Analyst Blog Highlights: NVR, PulteGroup, Taylor Morrison and M/I",PHM,en,Zacks Investment Research
2019-05-23 08:30:52-05:00,Why Is PulteGroup (PHM) Up 0.8% Since Last Earnings Report?,PulteGroup (PHM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.,PHM,en,Zacks Investment Research
2019-05-16 21:29:33-05:00,PulteGroup adds $500M to stock buyback program,No summary available.,PHM,en,Seeking Alpha
2019-05-15 18:23:44-05:00,PulteGroup (PHM) Presents At JP Morgan Homebuilding & Building Products Conference - Slideshow,"The following slide deck was published by PulteGroup, Inc. in conjunction with this event.",PHM,en,Seeking Alpha
2019-05-09 08:38:27-05:00,PulteGroup declares $0.11 dividend,"PulteGroup (PHM) declares $0.11/share quarterly dividend, in line with previous. Forward yield 1.41% Payable July 3; for shareholders of record June 14; ex",PHM,en,Seeking Alpha
2019-05-02 09:20:06-05:00,Will PulteGroup (PHM) Gain on Rising Earnings Estimates?,"PulteGroup (PHM) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.",PHM,en,Zacks Investment Research
2019-04-28 15:05:00-05:00,PulteGroup's Management Changes Its Tune on the Housing Market,"After delivering a discouraging market outlook three months ago, PulteGroup seems more optimistic about 2019.",PHM,en,The Motley Fool
2019-04-23 15:28:28-05:00,PulteGroup Inc (PHM) Q1 2019 Earnings Call Transcript -- The Motley Fool,"PHM earnings call for the period ending March 31, 2019.",PHM,en,The Motley Fool
2019-04-23 13:51:23-05:00,PulteGroup's (PHM) CEO Ryan Marshall on Q1 2019 Results - Earnings Call Transcript,No summary available.,PHM,en,Seeking Alpha
2019-04-23 11:53:47-05:00,"PulteGroup, Inc. 2019 Q1 - Results - Earnings Call Slides",No summary available.,PHM,en,Seeking Alpha
2019-04-23 06:07:30-05:00,UPDATE 1-Pulte new home orders top forecasts as mortgage rates ease,"PulteGroup Inc beat analysts' estimates for first-quarter profit on Tuesday, as demand for new houses benefited from a fall in mortgage rates due to the Federal Reserve's reining in its campaign of monetary tightening.",PHM,en,Reuters
2019-04-23 06:06:13-05:00,"PulteGroup +2.5% on better-than-expected Q1, renewed demand","PulteGroup (PHM) surges 2.5% in premarket trading after reporting renewed demand for housing. ""Helped by the recent decline in mortgage rates, homebuyers h",PHM,en,Seeking Alpha
2019-04-23 05:38:34-05:00,Homebuilder PulteGroup profit falls 2.3 percent,"PulteGroup Inc on Tuesday reported a 2.3 percent fall in first-quarter profit, hit by higher costs.",PHM,en,Reuters
2019-04-23 05:33:32-05:00,"PulteGroup beats by $0.12, beats on revenue",No summary available.,PHM,en,Seeking Alpha
2019-04-22 16:30:54-05:00,PulteGroup Q1 2019 Earnings Preview,No summary available.,PHM,en,Seeking Alpha
2019-04-18 04:24:00-05:00,Will Lower Deliveries Impact PulteGroup's (PHM) Q1 Earnings?,Ongoing housing market uncertainties and rising material prices are likely to hurt PulteGroup's (PHM) Q1 results.,PHM,en,Zacks Investment Research
2019-04-16 09:31:30-05:00,Earnings Preview: PulteGroup (PHM) Q1 Earnings Expected to Decline,PulteGroup (PHM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.,PHM,en,Zacks Investment Research
2019-04-10 10:27:34-05:00,"KB Home +1.3%, PulteGroup +0.7% after JPMorgan upgrades",No summary available.,PHM,en,Seeking Alpha
2019-04-10 07:21:58-05:00,PulteGroup partners with Finicity to simplify mortgage process,No summary available.,PHM,en,Seeking Alpha
2019-03-31 16:35:05-05:00,PulteGroup Q1 Earnings Preview,No summary available.,PHM,en,Seeking Alpha
2019-03-27 13:46:00-05:00,Homebuilders rally as drop in mortgage rates spurs demand,"Homebuilders rallied Wednesday after Mortgage Bankers Association data showed mortgage rates fell unexpectedly last week. Homebuilders KB Home and Lennar reported first quarter results between Tuesday's closing bell and Wednesday's open. Watch KB Home and Lennar trade live. The homebuilders were rallying after Wednesday after data showed last week's drop in mortgage rates propped up mortgage applications. Adding to the strength were quarterly reports from two of the nation's largest builders that forecast new-home orders ahead of expectations. Applications for mortgages surged 8.9% last week following an ""unexpected drop"" in rates, according to Mortgage Bankers Association data released Wednesday. ""The spring buying season is off to a strong start,"" said Joel Kan, MBA's associate vice president of economic and industry forecasting. ""Thanks to an unexpectedly large drop in mortgage rates following last week's FOMC meeting, purchase applications jumped 6 percent and refinance applications surged over 12 percent.",PHM,en,Business Insider
2019-03-25 16:06:21-05:00,PHM Crosses Above Key Moving Average Level,In trading on Monday shares of PulteGroup Inc Symbol PHM crossed above their 200 day moving average of 27 04 changing hands as high as 27 23 per share PulteGroup Inc shares are currently trading up about 2 4 on the day The chart below shows the one year performance of PHM shares,PHM,en,Nasdaq
2019-03-04 17:02:16-05:00,PulteGroup (PHM) Presents At Raymond James 40th Institutional Investors Conference - Slideshow,No summary available.,PHM,en,Seeking Alpha
